ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in … – BioSpace
SAN MATEO, Calif. and SINGAPORE, Dec. … Eblasakimab is a potential first-in-class monoclonal antibody targeting the IL-13 receptor that has the …
SAN MATEO, Calif. and SINGAPORE, Dec. … Eblasakimab is a potential first-in-class monoclonal antibody targeting the IL-13 receptor that has the …